Description
Join us for an insightful webinar on the groundbreaking advancements in canine oncology through the use of liquid biopsy technology. This presentation, targeted at veterinarians and specialised veterinary oncologists, will delve into the early diagnosis and monitoring of canine cancer using CanCan Diagnostics' innovative K9-LiquiDX™. Developed as a spin-out from the University of Edinburgh and launched in March 2024, K9-LiquiDX™ employs next-generation sequencing (NGS) to detect circulating tumor DNA (ctDNA) from a simple blood draw.
Discover how this minimally invasive technique enables sensitive and accurate monitoring for relapse, monitoring overall disease progression and tailored treatment strategies. We will discuss clinical validation, highlighting an 80% sensitivity and 92% specificity based on extensive trials. Attendees will also explore case studies demonstrating the real-world impact of early intervention on patient outcomes and quality of life.
This webinar promises to enhance your understanding of liquid biopsy applications in veterinary oncology, offering a powerful tool for improving diagnostic accuracy and patient care. Don't miss this opportunity to stay at the forefront of veterinary cancer diagnostics.
Learning Objectives
- Develop Personalized Treatment Strategies: Attendees will learn how to use comprehensive genetic profiles obtained from liquid biopsies to develop personalised treatment strategies tailored to individual canine cancer patients.
- Apply Next-Generation Sequencing (NGS) in Veterinary Practice: Vets will understand how to integrate NGS-based liquid biopsy into their practice, including sample collection, processing, and interpreting results to make informed clinical decisions.
- Interpret Clinical Validation Data: Attendees will be able to interpret the clinical validation data for K9-LiquiDX™, including its sensitivity, specificity, and real-world case study outcomes.
- Recognise the Benefits of Early Cancer Relapse Detection and Monitoring: Participants will learn about the advantages of early cancer relapse detection and ongoing monitoring in dogs, and how these practices can improve treatment outcomes and quality of life for pets.
- Understand Liquid Biopsy Technology: Attendees will gain a comprehensive understanding of liquid biopsy technology, including its principles, methodology, and how it applies to canine oncology.
